Peptides for muscle growth: what TikTok gets right and wrong

What's this video probably claiming?

Based on the caption, @jccarmella is offering a categorical breakdown of peptides for muscle and fitness goals, splitting them into two broad buckets: growth hormone (GH) peptides and IGF-1 peptides. The GH category likely includes compounds like CJC-1295, ipamorelin, and possibly MK-677, which is technically a GH secretagogue rather than a true peptide. The IGF-1 category probably references something like IGF-1 LR3 or mechano growth factor. The framing around "recovery, fat loss, sleep, and muscle growth" is a classic gym-content cluster of benefits that shows up constantly in fitness TikTok. Given the hashtags, this is aimed at recreational gym-goers, not clinical patients. The video is almost certainly not discussing FDA approval status, compounding regulations, or the difference between research-grade and pharmaceutical-grade compounds, which matters enormously for anyone actually considering these substances.

What does the science actually show?

The GH secretagogue research is real but more complicated than a TikTok caption suggests. Ipamorelin combined with CJC-1295 does increase pulsatile GH secretion in clinical studies. Sigalos and Pastuszak (2018, Current Sexual Health Reports) reviewed GH secretagogues and confirmed measurable GH and IGF-1 elevation, but noted that translating this into meaningful lean mass gains in healthy, eugonadal adults is far less consistent than the fitness community implies. A 2020 meta-analysis by Sinha et al. in the Journal of Clinical Endocrinology found GH secretagogues improved body composition primarily in GH-deficient populations, not healthy athletes. MK-677 (ibutamoren) at 25mg daily over 8 weeks did increase IGF-1 by roughly 60% in a Patchett et al. trial, but also increased fasting glucose and water retention. IGF-1 peptides like IGF-1 LR3 have almost no controlled human trial data outside of clinical GH deficiency contexts. The mechanistic story is plausible. The practical gym benefit story, at the doses and compounds circulating online, is largely extrapolated from that mechanism.

Where does the social media noise diverge from clinical reality?

The biggest gap is the implied accessibility and safety of these compounds. Most GH peptides referenced in gym content are not FDA-approved for muscle building or fat loss in healthy individuals. CJC-1295 with DAC, ipamorelin, and IGF-1 LR3 are available only as compounded preparations or research chemicals, which carries significant quality-control risk. The FDA issued warnings in 2023 specifically about compounded peptides being removed from the 503A and 503B bulk drug substance lists. The "sleep and recovery" framing for GH peptides is real in mechanistic terms since GH secretion does peak during slow-wave sleep, but presenting this as a straightforward benefit glosses over side effects including cortisol blunting, fluid retention, and potential insulin resistance flagged in longer-duration MK-677 studies (Copinschi et al., 1997, Sleep). Calling IGF-1 peptides a "muscle cell growth" tool without mentioning that IGF-1 elevation is also associated with cancer cell proliferation risk in some contexts (Renehan et al., 2004, Lancet) is a meaningful omission for a public-facing video.

What should you actually know?

The categorical framework this video is using is not wrong as a starting point. GH secretagogues and IGF-1 modulators do work through different pathways. But the clinical evidence for muscle-building benefits in healthy adults is thin, and the regulatory and safety picture is one that gym TikTok consistently skips. Anyone genuinely interested in peptide therapy should understand that legitimate use happens through licensed telehealth providers who can assess baseline GH and IGF-1 levels, not through a supplement stack assembled from a TikTok comment section. The compounding pharmacy landscape has also shifted significantly since 2023, and access to many of these compounds through legal channels is narrower than it was two years ago. If a creator is not discussing FDA status, compounding regulations, or the need for baseline bloodwork, they are giving you half a picture at best. The mechanism is interesting. The real-world application requires a lot more nuance than a category list.